NCT05370521 2025-10-09A Study of Safety and Efficacy of Tildacerfont in Females With Polycystic Ovary Syndrome and Elevated Adrenal AndrogensSpruce BiosciencesPhase 2 Terminated27 enrolled 18 charts
NCT02500147 2025-07-02Metformin for Ectopic Fat Deposition and Metabolic Markers in Polycystic Ovary Syndrome (PCOS)Columbia UniversityPhase 4 Terminated3 enrolled 5 charts
NCT02521753 2025-04-01OMgObPCOSCoordinación de Investigación en Salud, MexicoPhase NA Terminated123 enrolled